Skye Peptides

Listings clearly state products are for laboratory research use only.

No therapeutic, dosing, or human-use claims anywhere in the listing.

Batch-tied COAs (HPLC purity + mass-spec identity) exist and are accessible.

Vial sizes and prices are listed clearly and consistently, no bait pricing.

A stated shipping, tracking, and reship/refund policy is published.

No unresolved counterfeit, non-delivery, or COA-forgery reports on file. 2026-08-29: THE STOREFRONT WENT LOGIN-GATED AT THE ROOT TODAY - this is the change. https://skyepeptides.com/, /library/, /test-reports/ and /refund_returns/ ALL 302 to /login/: 'Please sign in to your account or register for a new account to enter the site.' No prices and no test reports are publicly viewable; no account was created. The only readable page is /home-2/ (robots: follow, noindex), which carries clean RUO framing - 'These products are intended strictly for in vitro research and laboratory use only... Administration to humans or animals is strictly prohibited' - plus 'Each peptide consistently meets or surpasses 99% purity' and 'Every batch is double tested with HPLC data provided.' reship_policy MOVES PENDING -> PASS on a first-hand stated policy: 'Due to regulations on the sale of our products, we cannot accept returns. If your order arrives incorrect or damaged, please contact us by email and we will arrange a replacement for you.' The check asks only whether a policy is stated; it is. coa_documentation and pricing_transparency remain PENDING BECAUSE OF THE GATE, NOT because anything adverse was seen. A directory listing for a store a visitor cannot browse is a materially different proposition - a listing note is recommended, same treatment as Cosmic. FINNRICK (SECONDARY, third-party, NOT SCORED) was not re-surfaced today; per the prior record the 11 May 2026 55% -> 28 Aug 2026 59% move is a METHODOLOGY RECALCULATION with NO NEW TEST BEHIND IT (latest underlying test still 11 May 2026, 0 corrections) and MUST be labelled as such if it is ever surfaced. Underlying figures unchanged: 42 of 75 classifiable tests passed, rank #287 of 307. || PRIOR: 2026-08-28: NO CHANGE, and the one number that moved must NOT be reported as an improvement. /test-reports/ still 302s to /login/ and /library/ is likewise behind the wall; the login-page footer still carries clean RUO plus both statutory carve-outs verbatim ('Skye Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A... is not an outsourcing facility as defined under 503B'). The five PENDING states are login gating - a read limitation, not evidence. THE FINNRICK SCORE MOVED 55% -> 59% ON A RECALCULATION DATED TODAY WITH NO NEW TEST BEHIND IT: the rating trend reads '11 May 2026: 55%' then '28 Aug 2026: current 59%', while the latest underlying test is STILL 11 May 2026 and corrections remain 0. That is a methodology artifact, not fresh evidence about the vendor, and if the number is ever surfaced it must be labelled as such. Otherwise flat: 42 of 75 classifiable tests passed, rank #287 of 307, 10 peptides; weakest CJC-1295 28%, Survodutide 37%, BPC-157 39%, Tesamorelin 44%; strongest Semaglutide 82%, Tirzepatide 78%. SECONDARY, a third-party assessment, NOT SCORED - the six-check list contains no quality criterion, which is Frank's standing question, fourth run. The undated Trustpilot allegation of a third-party shipper demanding an undisclosed $100 'insurance fee' is carried, UNDATED, unverified, not scored, and not publishable as fact. || PRIOR: 2026-08-27: NO MOVEMENT IN EITHER DIRECTION. Finnrick is FLAT on every figure: 59% rating, 42 of 75 classifiable tests passed, rank #287 of 307, 10 peptides, latest test on file 11 May 2026, 0 corrections. Weakest lines CJC-1295 28%, Survodutide 37%, BPC-157 39%, Tesamorelin 44%; strongest Semaglutide 82%, Tirzepatide 78%. Finnrick's own summary notes 'batch-ID gaps, overfill history, and narrow same-batch coverage keep consistency uncertain' - that is a SECONDARY third-party assessment, NOT a first-hand observation, and it is not treated as an independent adverse finding. LOGIN GATING UNCHANGED: /test-reports/ and /library/ both 302 to /login/, so the COA route is gated too and five checks carry prior state as limitations, never downgrades. The login page footer does carry clean RUO ('all products featured on this website are intended exclusively for research and development purposes... not designed for any form of human consumption') plus the 503A/503B non-compounder statement. THE $100 'INSURANCE FEE' ALLEGATION NOW HAS READABLE TEXT BUT REMAINS UNDATED AND UNSCORED. A locale-mirror workaround (it.trustpilot.com) returned review bodies after six consecutive bot-blocks on www.trustpilot.com. The complaint: order confirmed, handed to a third-party shipper who then demanded an undisclosed $100 'insurance fee', described as bait-and-switch; refund refused, customer ghosted. TWO FURTHER NEGATIVE REVIEWS on the same mirror, also undated: 'I'm not sure what they sent but it wasn't Tirzepatide', and an MT-1 adverse-reaction/ER report. THE MIRROR STRIPS REVIEW DATES, so none of these can be placed in time and NONE IS SCORED. They are recorded because an identity/adverse-event allegation is the kind of thing that must not be lost, and because a browser session could date them. FRANK'S STANDING QUESTION IS UNCHANGED AND STILL UNANSWERED, third run: does a Finnrick pass-rate this low warrant a flag under a quality criterion the six-check list does not currently contain? It would live naturally under the proposed seventh 'claims match documents' check. || PRIOR: 2026-08-26: SCORE FLAT, RELATIVE POSITION SLIPPED, AND THE GATING IS NOW BROADER THAN RECORDED. Finnrick first-hand today: 59% rating, 42 of 75 classifiable tests passed, RANK #287 OF 307 VENDORS - yesterday it was #280 of 301. The score did not move; the denominator grew, so Skye fell seven places. Weakest per-peptide: CJC-1295 28%, Survodutide 37%, BPC-157 39%, Tesamorelin 44%. Latest test on file is 11 May 2026 and the trend series ends '26 Aug 2026: current 59%'. This remains the strongest adverse quality signal in the directory. NEW: THE GATING NOW COVERS THE COA ROUTE TOO - /test-reports/ itself 302s to /login/, not just the catalog; the cart's 'Return to Shop' points at /library/. So no COA, price, claim or shipping term is publicly readable. coa_documentation, pricing_transparency, no_health_claims and reship_policy all sit at PENDING as access limitations, NOT adverse findings. In the vendor's favour, the public login page footer does carry clean RUO plus BOTH 503A and 503B disclaimers. no_scam_flags HELD AT PASS, and the reasoning matters: repeated purity/dose test failure is a QUALITY signal, not counterfeit, non-delivery or COA forgery, and the six-check list has no quality criterion - so scoring it under no_scam_flags would be misusing the check. FRANK'S STANDING QUESTION IS UNCHANGED AND STILL UNANSWERED: does a Finnrick pass-rate this low warrant a flag under a quality criterion the six-check list does not currently contain? This is the second consecutive run asking. See also the seventh-check recommendation in today's report - a 'claims match documents' criterion would give this finding somewhere to live. The undated Trustpilot allegation of an undisclosed $100 third-party-shipper 'insurance fee' remains UNVERIFIED - search-summary only, no primary source opened, no date. It would be material if real; it is not evidence yet. || PRIOR: 2026-08-25: THE STRONGEST ADVERSE QUALITY SIGNAL IN THE DIRECTORY SURFACED TODAY, AND IT IS DELIBERATELY NOT SCORED AS A SCAM FLAG. Finnrick was read FIRST-HAND: Skye Peptides rates 59%, RANKED #280 OF 301 VENDORS, with 42 of 75 classifiable tests passed - 33 FAILURES. Per-peptide: CJC-1295 28%, Survodutide 37%, BPC-157 38%, Melanotan II 45%, Tesamorelin 45%. Finnrick's own analysis cites 'batch-ID gaps, overfill history, and narrow same-batch coverage'. The trend line shows '25 Aug 2026: current 59%', i.e. refreshed today. no_scam_flags IS HELD AT PASS ON PURPOSE: this is repeated purity/dose failure, which is a QUALITY problem, and the published six-check list defines no_scam_flags narrowly as counterfeit, non-delivery or COA-forgery reports. Stretching a scam check to cover purity data would be exactly the kind of unwritten-criterion drift this file exists to prevent. ESCALATED TO FRANK AS A RULE QUESTION INSTEAD: does a third-party pass rate this low warrant a flag under a quality criterion the checklist does not currently contain? That is a checklist gap, not a vendor accusation. SECOND MOVEMENT: reship_policy PASS -> PENDING. The storefront is now fully login-gated (/login/ confirms the shop lives at /library/) and NO shipping, refund or returns link is exposed anywhere on the public page. Gated, not adverse. coa_documentation stays pending for the same reason - public COA PDFs exist in uploads (TrustPointe, MZ Biolabs) but no batch-tie is possible without an account. Footer RUO + 503A/503B disclaimer verbatim, so framing passes. UNVERIFIED AND UNDATED, RECORDED NOT SCORED: a Trustpilot review alleges a third-party shipper demanded an undisclosed $100 'insurance fee' not shown at checkout, then went unresponsive on the refund request - a classic advance-fee pattern that WOULD be material if real, but Trustpilot returned an empty body and no date could be established, so it cannot be placed in any review window. Needs a browser-based read before it moves anything. Separately UNVERIFIED: a clone domain skiepeptide.com reportedly impersonates Skye to harvest payment info - that is adverse to the LOOK-ALIKE, not to skyepeptides.com, and is recorded here so it is never misattributed. || PRIOR: 2026-08-24: FETCH RECOVERED after yesterday's failure — but the storefront is now FULLY LOGIN-GATED first-hand: /product-category/peptide/ 302s to /login/ ('register to enter the site'), so catalog, pricing, AND shipping/refund policy pages are unverifiable from outside. pricing_transparency and reship_policy move to first-hand PENDING (gated, not adverse). Login page carries full RUO + 503A/503B disclaimer (research_use_framing pass). Some COA PDFs remain publicly reachable in uploads (TrustPointe Analytics, MZ Biolabs, 2026-03 endotoxin report e.g. sk26-05-001) but batch-tie to current listings unconfirmable without an account. Look-alike domain swarm (skyepeptides.us.com, skiepeptide.com, skyepeptidesllc.com) advertising weight-loss uses remains a sector note NOT attributed to this vendor. || PRIOR: 2026-08-23: NO FIRST-HAND READ — fetch failure this run (tooling provenance restriction, not a confirmed site outage); all six carried unchanged. RECORDED NOT SCORED: search surfaced a SWARM of look-alike domains outranking the real site — skyepeptides.us.com, skyespeptides.co, skiepeptide.com (previously identified clone), skyepeptidesinc.com, skyepeptidesstore.com, skyepeptidesllc.com, skyepeptidesllcs.com — several openly advertising weight-loss/muscle-growth uses. NOT attributed to the vendor, but a customer-misdirection risk worth surfacing on the vendor page. Trustpilot page returned empty on fetch; no new attributable reports Aug 21-23. || PRIOR: 2026-08-19: NO FIRST-HAND READ - the account wall is unchanged and the storefront remains unassessable from outside. SECONDARY-ONLY SIGNAL RECORDED AND EXPLICITLY NOT SCORED: aggregator and Trustpilot summaries this run describe a mixed picture - praise for customer service, pricing, shipping speed and batch testing [...earlier history truncated - see compliance-reports/ for the full record...]